UK markets open in 4 hours 43 minutes

TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
12.60+0.10 (+0.80%)
As of 09:40AM CST. Market open.
Currency in TWD

Valuation measures4

Market cap (intra-day) 924.00M
Enterprise value 866.34M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)40.63
Price/book (mrq)13.80
Enterprise value/revenue 38.09
Enterprise value/EBITDA -498.76

Trading information

Stock price history

Beta (5Y monthly) -0.34
52-week change 3-60.06%
S&P500 52-week change 321.23%
52-week high 332.45
52-week low 312.25
50-day moving average 313.76
200-day moving average 315.40

Share statistics

Avg vol (3-month) 3207.15k
Avg vol (10-day) 3205.37k
Shares outstanding 575.12M
Implied shares outstanding 676.95M
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2022

Profitability

Profit margin -26.59%
Operating margin (ttm)-551.04%

Management effectiveness

Return on assets (ttm)-5.39%
Return on equity (ttm)-8.73%

Income statement

Revenue (ttm)22.74M
Revenue per share (ttm)0.30
Quarterly revenue growth (yoy)2,971.00%
Gross profit (ttm)N/A
EBITDA -5.29M
Net income avi to common (ttm)-6.05M
Diluted EPS (ttm)-0.08
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)60.69M
Total cash per share (mrq)0.81
Total debt (mrq)1.86M
Total debt/equity (mrq)2.59%
Current ratio (mrq)10.43
Book value per share (mrq)0.89

Cash flow statement

Operating cash flow (ttm)-821k
Levered free cash flow (ttm)2.15M